| NDC Code | 69097-221-12 |
|---|
| Package Description | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (69097-221-12) |
|---|
| Product NDC | 69097-221 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Ranolazine |
|---|
| Non-Proprietary Name | Ranolazine |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20190528 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA211291 |
|---|
| Manufacturer | Cipla USA Inc. |
|---|
| Substance Name | RANOLAZINE |
|---|
| Strength | 500 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
|---|